NantKwest

$7.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-0.66%) Today
-$0.14 (-1.86%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NantKwest and other stocks, options, and ETFs commission-free!

About NK

NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. The listed name for NK is NantKwest, Inc. Common Stock.

CEO
Richard Adcock
Employees
148
Headquarters
San Diego, California
Founded
2002
Market Cap
818.79M
Price-Earnings Ratio
Dividend Yield
Average Volume
566.02K
High Today
$7.77
Low Today
$7.42
Open Price
$7.66
Volume
335.66K
52 Week High
$15.70
52 Week Low
$1.23

Collections

NK Earnings

-$0.25
-$0.17
-$0.08
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 24, After Hours

You May Also Like